SARS-CoV-2 co-infections during an ongoing phase III common cold trial.

Peter L Friedland

Published in: Internal medicine journal (2023)

Keyphrases

phase iii
sars cov
open label
clinical trial
phase ii
respiratory syndrome coronavirus
double blind
placebo controlled
coronavirus disease